Skip to search formSkip to main contentSkip to account menu

DU 6859A

Known as: DU-6859A 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Spiro Compoundssitafloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
anaerobic bite wound isolates. ciprofloxacin against 387 aerobic and levofloxacin, ofloxacin, sparfloxacin, and Comparative in vitro activities of DU-6859a,
Abstracts of the 34thInterscience Conference on Antimicrobial Agents and Chemotherapy.American Society for Microbiology… 
2012
2012
Preference for Costly Fluoroquinolones by Casual Workers and Daily Wage Earners in Developing Countries
Existing quinolones, as well the newer products such as DU-6859a, have a large market potential in developing countries. During… 
1999
1999
Comparative Postantibiotic Effect of Sitafloxacin and Trovafloxacin on Methicillin-Resistant Staphylococcus aureus
Sitafloxacin (DU-6859a) and trovafloxacin are newer fluoroquinolones that possess potent in vitro activity against methicillin… 
1998
1998
Effects of DU-6859 a , a New Quinolone Antimicrobial , on Theophylline Metabolism in In Vitro and In Vivo Studies
In vitro and in vivo studies were conducted to investigate the drug interaction between a new quinolone antimicrobial, DU-6859a… 
1997
1997
Comparative In Vitro Activity and Killing Effect of Trovafloxacin, DU-6859a, Levofloxacin and Sparfloxacin against Staphylococcus aureus
SummaryThe predominance of quinolone resistance among methicillin-resistant Staphylococcus aureus (MRSA) isolates in the… 
1997
1997
抗菌薬投与法の breakpoint MIC の実験的推定 DU-6859a 経口 50 mg×2/日投与における中等度複雑性尿路感染症に対する breakpoint MIC の検討
1993
1993
Pharmacokinetics and safety investigation of a new fluoroquinolone, DU-6859a in health male volunteers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)